Louisiana State University

LSU Digital Commons
LSU Master's Theses

Graduate School

July 2019

Infection Potential of Rickettsia felis via Ingestion
Matthew M. Schexnayder
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses
Part of the Bacteria Commons, Bacteriology Commons, Medical Microbiology Commons, Pathogenic
Microbiology Commons, Veterinary Infectious Diseases Commons, and the Veterinary Pathology and
Pathobiology Commons

Recommended Citation
Schexnayder, Matthew M., "Infection Potential of Rickettsia felis via Ingestion" (2019). LSU Master's
Theses. 4978.
https://digitalcommons.lsu.edu/gradschool_theses/4978

This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has
been accepted for inclusion in LSU Master's Theses by an authorized graduate school editor of LSU Digital
Commons. For more information, please contact gradetd@lsu.edu.

INFECTION POTENTIAL OF RICKETTSIA FELIS VIA INGESTION

A Thesis
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Master of Science
in
The Department of Pathobiological Science

by
Matthew M. Schexnayder
B.A., Louisiana State University 2012
D.V.M., Louisiana State University 2016
August 2019

May greater glory, love unending
be forever thine.

ii

ACKNOWLEDGEMENTS
First and foremost, I would like to thank Dr. Kevin R. Macaluso for readily accepting me
into his lab and for offering me the chance to take on an exciting and meaningful project. His
easy-going nature and sense of humor have been a breath of fresh air in the too-often stuffy
atmosphere of higher academia. He has endeavored to fill his lab with wonderful people and has
treated them well, never missing birthdays and ensuring everyone had a family for holidays,
though they might be far from home. He truly is a remarkable person and the scientific
community is better because of him.
I would like to thank my predecessor Dr. Kelsey Legendre for pioneering infective flea
feces research, handing me the map, and teaching me to navigate. Likewise, I am indebted to
Hanna Laukaitis, my fearless peer and constant aide; without her brilliance, this manuscript
would still be months away, and I am thrilled to understand just enough now to follow her future
success. I extend my thanks to the remaining members of the Macaluso lab: Krit Jirakanwisal,
Natthida Tongluan, Dr. Chanida Fongsaran, Dr. Rebekah Bullard, Dr. Monika Bohácsová,
Chanakan Suwanbongkot, and Sabrina Valdes. They have provided me with patient assistance
and understanding of my wayward schedule. I must additionally thank Dr. Ingeborg Langohr and
Dr. Mariano Carossino for their collaboration.
My thanks also go out to the additional members of my defense committee, Dr. Lane Foil
and Dr. Stephen Gaunt, as well as my clinical pathology mentor Dr. Shannon Dehghanpir and
resident mate Dr. Annie Bauman for the generous contributions of their time during the process
of thesis preparation and defense.

iii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS ........................................................................................................... iii
LIST OF TABLES .......................................................................................................................... v
LIST OF FIGURES ....................................................................................................................... vi
ABSTRACT .................................................................................................................................. vii
CHAPTER 1. THE CASE FOR INGESTION AS A POTENTIAL ROUTE OF RICKETTSIA
FELIS INFECTION ........................................................................................................................ 1
1.1.

A Review of Rickettsia ..................................................................................................... 1

1.2.

The Current Understanding of Rickettsia felis as an Emerging Pathogen ....................... 3

1.3.

Ingestion as a Route of Infection of Similar Pathogens ................................................. 14

1.4.

Summary ........................................................................................................................ 16

CHAPTER 2. INFECTION POTENTIAL OF RICKETTSIA FELIS VIA INGESTION ............ 18
2.1. Introduction ........................................................................................................................ 18
2.2. Materials & Methods ......................................................................................................... 19
2.3. Results ................................................................................................................................ 27
CHAPTER 3. DISCUSSION & FUTURE DIRECTIONS .......................................................... 33
BIBLIOGRAPHY ......................................................................................................................... 40
VITA ............................................................................................................................................. 50

iv

LIST OF TABLES
Table 1. Detection of R. felis from culture via qPCR ................................................................... 28
Table 2. Detection of R. felis from flea feces via qPCR ............................................................... 32

v

LIST OF FIGURES
Figure 1. A timeline of Rickettsia felis milestones ....................................................................... 13
Figure 2. Rickettsia felis inside ISE6 cells .................................................................................... 19
Figure 3. Per oral administration of Rickettsia felis from culture ................................................. 21
Figure 4. Per oral administration of Rickettsia felis from flea feces ............................................. 23
Figure 5. Histopathology of mouse samples post-ingestion of R. felis from culture .................... 29
Figure 6. Anti-Rickettsia immunohistochemistry of mouse spleen post-ingestion of R. felis
from culture ................................................................................................................................... 30
Figure 7. Indirect immunofluorescence assay of mouse serum post-ingestion of R. felis from
culture ........................................................................................................................................... 31

vi

ABSTRACT
Rickettsia felis is the etiologic agent of flea-borne spotted fever (FBSF) in humans and a
poorly described cause of fever in animals. It is transmitted by its primary arthropod vector and
reservoir host, the cat flea Ctenocephalides felis. Known routes of Rickettsia felis transmission
between Rickettsia felis-infected cat fleas and vertebrate hosts include cutaneous bites and
contamination of cutaneous wounds with infective flea feces. The bulk of FBSF infections occur
in young children in Africa, though infections of people at all ages all over the world have been
confirmed. As mammals and young children frequently come into contact with flea feces through
routine grooming and indiscriminate oral hygiene, respectively, we speculate that ingestion of
infective flea feces may potentially account for a portion of natural Rickettsia felis infections. To
investigate the potential role ingestion of Rickettsia felis plays in transmission of the bacterium to
vertebrates, we designed sister experiments using a BALB/c mouse model to determine 1) if
Rickettsia felis could establish an infection via an oral route and 2) if Rickettsia felis could
establish an infection via an oral route in the form of infective cat flea feces. For our first
objective, Rickettsia felis was cultured in ISE6 cells, purified, and administered orally in SPG
buffer. Our second objective was executed by feeding a viable Rickettsia felis-spiked blood meal
to Ctenocephalides felis, collecting infective flea feces, and administering the feces orally in
SPG buffer. In both experiments necropsy was performed at 1, 7, and 14 days post-exposure and
heart, liver, spleen, stomach, and intestine were collected for DNA extraction, RNA extraction,
and qPCR analysis. Tissues with positive results were subsequently submitted for histopathology
using hematoxylin and eosin staining as well as anti-Rickettsia immunohistochemistry. Select
tissues were tested via RT-qPCR and a single serum sample via an indirect immunofluorescence
assay. Our results indicate that R. felis from culture is transmissible via ingestion in mice and
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may be found in organs distant from the gastrointestinal tract at all time-points tested without
evoking inflammation. Further studies are needed to characterize all aspects of R. felis
transmission via ingestion in vertebrates.
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CHAPTER 1. THE CASE FOR INGESTION AS A POTENTIAL ROUTE
OF RICKETTSIA FELIS INFECTION
1.1. A Review of Rickettsia
The genus Rickettsia belongs to the order Rickettsiales (phylum Proteobacteria, class
Alphaproteobacteria) which derives from a distant ancestor that diverged from mitochondria
after colonizing single-celled organisms 2,000-1,500 million years ago [1]. As a consequence of
the Cambrian Explosion ushering in the majority of characteristically multicellular metazoan
phyla, members of Rickettsiales started infecting eukaryotes, notably early arthropods, around
525-425 million years ago [2, 3]. Rickettsia began to diverge from the closely related genus
Orientia around 225-150 million years ago and subsequently evolved to occupy ecological
niches as the hydra, torix, and arthropod-associated clades [2]. The former two clades are known
parasites of many protists and leeches, however, there is debate whether the arthropod-associated
Rickettsia initially infected protists and later adapted to infecting arthropods [2]. This theory is
logically supported by the idea that early arthropods were exposed to Rickettsiales via ingestion
of their protist hosts. Protists emerged far sooner than arthropods, the first multicellular protists
as early as 1,200 million years ago [4-6], indicating a significantly longer period of co-habitation
with Rickettsiales. Moreover, genomic sequencing of Rickettsia bellii has revealed genes related
to amoebal symbionts, suggesting an ancient horizontal gene transfer event occurred [1, 7, 8].
Rickettsia first came under scientific scrutiny through the eyes of Howard Taylor
Ricketts, an American pathologist whose 1907-1909 investigation into Rocky Mountain Spotted
Fever led him to correctly describe the etiologic agent Rickettsia rickettsii as a pleomorphic
bacillus isolated from the salivary glands, alimentary sac, and ovaries of ticks [9, 10]. In the
following decades small intracellular bacteria that were unable to be isolated or otherwise

grouped were described as rickettsiae [1], particularly if they were gram negative, difficult to
culture, and borne by hematophagous arthropods. Classically, Rickettsia have been placed into
two key groups based on arthropod vector, optimal growth temperatures, antigenic
characteristics, and clinical signs associated with disease [10-12]. These main groups include the
spotted fever group (SFG) composed of Rickettsia species typically transmitted by ticks and the
typhus group (TG) made up of Rickettsia species transmitted predominantly via fleas or lice [1,
11]. With the dawn of molecular diagnostics, whole genome sequencing, gene banking, and
computational phylogenetics, over 30 Rickettsia species and many strains have been identified
[2, 10] and a few species erroneously classified as Rickettsia – such as Coxiella burnetti, the
causative agent of Q fever – have been removed [10]. A landmark phylogenetic study published
by Gillespie et al in 2007 established the transitional group (TRG) and rooted Rickettsia
phylogeny to the ancestral group (AG), defining four distinct modern lineages of Rickettsia [8,
13, 14]. TRG rickettsiae, consisting chiefly of Rickettsia felis, Rickettsia akari, and Rickettsia
australis, share features of both the SFG and TG rickettsiae [1, 8, 13]. SFG rickettsiae
demonstrate increased sequence homogeneity relative to other clades and are capable of entering
the host cell nucleus through the polymerization of actin [1]. TG rickettsiae are partially
characterized by highly reductive genomes [13], a common theme amongst intracellular
symbionts as they become increasingly reliant on host metabolic pathways [3] – and increasingly
pathogenic [1]. In contrast with the other clades, members of the basal AG are largely considered
non-pathogenic to vertebrates [2].
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1.2. The Current Understanding of Rickettsia felis as an Emerging Pathogen
1.2.1. Discovery, Characterization, and Organization
A minor debate persists regarding the original point of discovery of Rickettsia felis. It has
been suggested that the organism was first described upon isolation from a European cat flea
(Ctenocephalides felis) in 1918 by H. Sikora who named it ‘Rickettsia ctenocephali’ [15, 16]
before it was subsequently forgotten. As this occurred prior to the molecular age, it is impossible
to determine if the organism Sikora described was truly the modern-day R. felis or simply the
other known flea-borne rickettsia, Rickettsia typhi [10]. Rather, the discovery is commonly
credited to Adams et al for their 1990 electron microscopy-based description of a rickettsia-like
organism in the midgut epithelial cells, myocytes, fat body, ovaries, and epithelial sheath of the
testes of a laboratory cat flea colony [15, 17-22]. Ironically, the flea colony was being used to
identify a vector for Ehrlichia risticii (renamed Neorickettsia risticii), the causative agent of
Potomac Horse Fever [22]. This incidentally identified organism – temporarily termed ‘ELB
agent’ for the flea supplier Elward Laboratory [17, 20-22] – was characterized as part of
Rickettsia in 1992 by Azad et al after successful amplification of a conserved genera-specific 17kDa protein antigen and a citrate synthase gene (gltA) [17, 20]. Through a series of specific
polymerase chain reaction (PCR) amplifications and restriction enzyme assays, Azad et al
determined that ELB agent more closely resembled TG Rickettsia than SFG Rickettsia [20], a
classification overturned in 2001 by Bouyer et al [22] who successfully demonstrated
amplification of the SFG-associated 190-kDa antigen gene (rompA). Meanwhile, Higgins et al
investigated eight laboratory colonies of cat fleas, identified a 43-93% prevalence range of ELB
agent, and subsequently proposed ELB agent be deemed Rickettsia felis [17, 22-24], which was
soon placed in the newly organized TRG [8].
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1.2.2. Distribution and Arthropod Association
R. felis exhibits a worldwide distribution, with positive identification on every continent
except for Antarctica [10, 11, 15, 17, 25, 26]. This sprawl is largely due to the nearly ubiquitous
presence of the cat flea (Ctenocephalides felis) [17, 26, 27], which has been considered the
primary vector of R. felis as well as its reservoir host owing to its ability to maintain the
bacterium in flea populations [24, 25, 28]. While R. felis bears a strong relationship with the cat
flea, it is only considered to be a facultative parasite of this species [18]. Furthermore, R. felis is
unique among rickettsiae in that it can infect both insect and acarine arthropod hosts [17, 29-32].
These arthropods have come to include over 10 other flea species, several species of ticks,
mosquitoes, mites, and chiggers, as well as a single report in a bed bug [15, 17, 25, 33, 34] and a
single non-hematophagous host, the book louse Liposcelis bostrychophila [35-37].
Transmission of R. felis within cat fleas has been shown to occur both vertically and
horizontally [19, 26, 28, 38-40]. Vertical transmission of R. felis between generations of cat fleas
was deemed plausible when the bacterium was noted in ovaries and the epithelial sheath of testes
[21]. In 2002 Wedincamp and Foil [28] demonstrated vertical transmission for up to 12
generations of cat fleas, indicating that both transovarial and transstadial maintenance of R. felis
occurs. They additionally noted that there were no negative effects of infection on host fitness,
such as reduced egg counts [28]. They did, however, report waning levels of R. felis past the F8
generation [28], suggesting that vertical transmission alone was unlikely to perpetually maintain
the infection in a single flea colony [26, 41]. In a separate study, Wedincamp and Foil reported
PCR detection of R. felis in feline blood and that laboratory cats became seropositive within four
months of exposure to R. felis-infected cat fleas, providing additional support for horizontal
transmission [42]. In 2008 Macaluso et al reported the presence of R. felis in the salivary glands
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of cat fleas observed with transmission electron microscopy and confirmed via PCR [19].
Finally, in 2011 Hirunkanokpun et al showed that horizontal transmission between cat fleas
occurs via both cofeeding – the sharing of a blood-meal between infected and naïve hosts – and
mating [38], while Reif et al demonstrated that cat fleas could become infected with R. felis via
an infective blood meal [43]. Brown et al went further in 2015, demonstrating cofeeding
transmission of R. felis between two different arthropod species (C. felis and Xenopsylla cheopis)
[26]. This hints at a greater complexity of R. felis transmission that is undoubtedly occurring in
sylvatic, suburban, and urban cycles [17]. Moreover, horizontal transmission for maintenance in
an arthropod host has been associated with increased pathogenicity in rickettsiae [14, 44].
1.2.3. Intraspecific Variation and Virulence
Several strains of Rickettsia felis have been identified to date. R. felis was first isolated in
pure culture from Ctenocephalides felis by Raoult et al in 2001 using a Xenopus laevis-derived
XTC-2 cell line [45]. This cultured line, designated as R. felis str. URRWXCal2 (alternatively
Marseille-URRWXCal2 or California 2), grew best at 28˚C and failed to grow at temperatures
>32 ˚C – a characteristic that supported the early placement of R. felis in the SFG rickettsiae [17,
45, 46]. In 2006 a novel isolate of R. felis str. URRWXCal2 (Pedreira) was successfully grown in
a C6/36 Aedes albopictus cell line [47]. In the same year a new strain of R. felis, R. felis str. LSU,
was isolated from C. felis and cultured in an ISE6 Ixodes scapularis cell line [48]. In 2010 Behar
et al identified R. felis in a non-hematophagous booklouse, Liposcelis bostrychophila; this strain
is not officially named and is referred to as “Aus-Lb” [37]. Similarly, R. felis str. LSU-Lb was
isolated from the same species of booklouse and was successfully grown in ISE6 cells by
Thepparit et al in 2011 at 32 ˚C [35]. Finally, a Rickettsia felis-like organism (RFLO) from
Asembo, Kenya, known as Candidatus Rickettsia asemboensis, was described by Jiang et al in
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2013 [49]. Currently, over 30 RFLOs have been identified in wild-caught arthropods worldwide
based on 0.2% divergence of the 16S rRNA (rrs) gene [25], however, caution has been advised
for future speciation based on low thresholds of genomic divergence [50], as phenotypic and
ecological relevance may be insignificant [25].
The genome of R. felis str. URRWXCal2 was first sequenced in 2005 by Ogata et al [46,
51]. Subsequently, Gillespie et al sequenced the genomes of R. felis str. LSU and R. felis str.
LSU-Lb in 2014 [14]. Comparison of the genomes revealed that the cat flea-associated strains
were minimally divergent and that the differences observed in LSU-Lb likely resulted from
adaptation to an endosymbiotic relationship with the booklouse [14]. Interestingly, it has been
shown that the booklouse requires R. felis for development of the oocyte, indicating a different
type of vector association as compared to the facultative parasitic relationships of flea-borne
rickettsiae [25, 36, 52].
The initial team sequencing URRWXCal2 estimated the presence of ~1,500 open reading
frames and two plasmids they named pRF and pRFδ, the first plasmids to be discovered in a
Rickettsia species [46]. Pornwiroon et al noted that strain LSU contained pRF but lacked pRFδ
[48], a finding later confirmed by Fournier et al who additionally discovered that strain
URRWXCal2 may lose pRFδ at high passage [53]. Similarly, other strains of R. felis have been
identified that occasionally lack plasmids altogether (e.g. strain RF2125) [53, 54]. Interestingly,
strain LSU-Lb contains pRF and a unique plasmid pLbaR [14]. In order to determine the effect
of strain (i.e. presence of pRF and pLbaR) on transmission, infection, and host fitness, Healy et
al infected C. felis with R. felis str. LSU-Lb for comparison with R. felis str. LSU [18].
Surprisingly, they found that strain LSU-Lb infected C. felis more efficiently than strain LSU
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[18], suggesting either that vector adaptation occurs despite variance in plasmids or that plasmids
play a minor role in host relationships of R. felis strains.
While the functions of these plasmids are still being explored, their presence and putative
as well as confirmed genes suggests several possibilities, including potential virulence genes as
well as release of effector molecules and horizontal gene transfer via components of a Type IV
Secretion System [8, 14, 46, 55-57]. Although R. felis and other vertebrate-associated rickettsiae
lack pathogenicity islands [1, 8, 58], prospective virulence genes of R. felis notably include
several sca genes, surface antigens variably involved in adhesion and actin-based motility (sca2),
including ompB and sca4 which have been universal among Rickettsia [46, 59-64]; a
hyaluronidase homolog pRF56 which bears sequence homology to Clostridium perfringens
hyaluronidase NagI [8, 46]; pat1 and paralog pat2 potential phospholipases [8, 46, 65, 66]; and
several genes for patatin-like proteins associated with hemolytic activity – a finding functionally
confirmed by dithiothreitol inhibition [46]. Of these, the most concerning for higher eukaryotes
is hyaluronidase, which is considered a “spreading factor” owing to its ability to digest the
extracellular matrix of animal tissues [8]. Similarly, R. felis also contains a chitinase, which
explains its ability to colonize arthropods [46]. Additionally, R. felis has several genes devoted to
antibiotic resistance, including resistance to streptomycin, class C and D Β-lactamases, and
penicillin [46]. Finally, pathogenicity is further implied by the reductive nature of the R. felis
genome, which has been associated with pathogenic phenotypes [1]. It has been proposed that
these deletions occurred either through relaxation of purifying selection [1, 67-69] or through
failed horizontal gene transfer [1, 70], each resulting in degraded genes or pseudogenes.
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1.2.4. Disease Association in Animals and Humans
While Rickettsia felis has been isolated from many arthropods, its primary vector and
reservoir host is the cat flea [15, 25], which has been found worldwide in close association with
vertebrates of sylvatic, suburban, and urban ecosystems. It is important to note that a definitive
mammalian host of R. felis has yet to be identified [17] and that the bacterium has not been
isolated from a vertebrate host [11, 25], leaving Koch’s postulates of disease causality
unfulfilled. Furthermore, Brown et al demonstrated that horizontal transmission of R. felis occurs
between cofeeding arthropods in the absence of bacteremia, suggesting that vertebrate
transmission and a subsequent systemic infection are not required for maintenance of R. felis in
arthropod hosts [26]. Consequently, the clinical significance of R. felis has been questioned [26,
71]. Though this may be, there remains a significant body of evidence that supports the role of R.
felis as a pathogen of both animals and humans.
While many companion animals are protected from hematophagous arthropods due to
diligent owners and preventative medications, neglected, stray, and wild animals are completely
exposed to such vectors. These animals play an important role in the health of humans as
sentinels of infectious disease, particularly in suburban and urban settings [72]. Since being
definitively identified in 1996, R. felis has been reported in association with mammals
worldwide. Stray cats and dogs, opossums, raccoons, and rats are considered reservoir hosts [22,
25]. Surveillance studies conducted in several countries have investigated the prevalence of R.
felis in the fleas of these species with rates that are mostly in agreement with the <25% for wildcaught fleas reported by Reif et al [38, 73-84]. Importantly, animals have been shown to mount
an antibody response to R. felis, as first documented by Wedincamp and Foil when their research
cats seroconverted within four months [17, 42, 85, 86], suggesting infection occurs in
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vertebrates. Furthermore, Mongkol et al correlated R. felis with fever, anemia, and petechia in
dogs by specifically collecting fleas and blood from dogs diagnosed with fever of unknown
origin (FUO) [76]. While their results provide evidence of R. felis-association in these clinically
ill dogs, it is uncertain which diagnostic tests these dogs received in order to rule-out other
etiologies, thus further studies are needed to refine this association. Currently, no articles related
to R. felis-associated disease in animals can be found in the Journal of the American Veterinary
Medical Association or the American Journal of Veterinary Research, suggesting that it has
largely been overlooked as a significant cause of concern in veterinary medicine. Likewise, R.
felis is not mentioned in the latest edition of The Textbook of Veterinary Internal Medicine [87].
The diagnosis of arthropod-borne illness in veterinary medicine is largely dependent on
microimmunofluorescence, direct immunofluorescence, and to a lesser extent serology and PCR
identification [87], methods with potential for interspecies cross-reactivity that have not been
fully delineated [10]. Moreover, empirical treatment is common practice in veterinary medicine,
and, considering the treatment for most arthropod-borne illnesses is a tetracycline antibiotic –
chiefly doxycycline – there is little pressure on practitioners to reach an absolute diagnosis.
Furthermore, one survey of veterinarians found that only 55.8% polled knew of R. felis and only
51.2% thought fleas posed a health risk to humans [88]. Therefore, the sparsity of hard evidence
supporting the affiliation of R. felis with animal disease is likely due to a combination of
effective preventative medicine against companion animal ectoparasites, a lack of need for an
absolute diagnosis in the treatment of arthropod-borne animal disease, a paucity of correlative
studies, and potentially a lack of primary and continuing education for veterinarians in regards to
arthropod-borne disease.
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The incidence of R. felis-associated disease is better documented in humans as compared
to animals and has been reported worldwide, notably in several endemic areas including large
swathes of sub-Saharan Africa, parts of Texas, and Los Angeles, California [11, 15, 89-91]. In
humans, R. felis-related disease is termed flea-borne spotted fever (FBSF) and has been
associated with clinical signs such as headaches, fever, chills, cough with or without pneumonia,
malaise, and myalgia, dermatologic signs such as a maculopapular rash or eschar, and rarely
more severe gastrointestinal or neurological signs such as photophobia, hearing loss, or
meningitis [11, 15, 89, 92-94]; many signs that occur with murine typhus (endemic typhus)
infections [25]. Murine typhus is caused by Rickettsia typhi and is similarly transmitted by fleas
in regions worldwide that commonly overlap with R. felis [11]. Consequently, FBSF has likely
been misdiagnosed as murine typhus for years [45]. Indeed, in 1994 the first confirmed human
case of FBSF was initially misdiagnosed as murine typhus in 1991 due to poor specificity of
serological testing for rickettsial diseases [95]. Since that time serology has improved and many
reports have identified seropositivity in humans, providing further evidence of R. felis exposure
and possible infection [76, 96-103]. Interestingly, a 2017 report by Teoh et al investigated the
incidence of seropositivity in veterinarians – a unique human niche consistently exposed to fleas
over the span of many years [88]. They found 16% of veterinarians were unequivocally positive
for exposure to R. felis and an additional 35.1% tested were seropositive either for R. felis or R.
tyhpi [88]. In a comical turn of biological retribution, veterinarians that failed to advocate for flea
prevention were significantly more likely to be seropositive [88].
Perhaps the most compelling case for zoonotic horizontal transmission of R. felis via fleas
was reported by Richter et al in 2002, detailing a couple and their dogs [104]. The couple each
developed a fever and maculopapular rash. A series of negative diagnostic results led physicians
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to eventually test for flea and tick-borne diseases as the couple reported that their dogs had been
infested with ectoparasites. Both the woman and one of her dogs had high titers for R. felis. The
presence of R. felis was later confirmed with Western blot and PCR analyses. Although no
ectoparasites were available from the dogs for testing, the physicians came to the logical
conclusion that the couple had been bitten by fleas or ticks from their dogs. While no conclusion
can be drawn regarding zoonotic horizontal transmission, the case provides solid evidence that
domestic exposure to ectoparasites can result in human disease [104].
In Africa fever rates have remained stagnant even though cases of malaria have declined
[105]. In the effort to discern causes for FUO, investigators have identified R. felis as a
significant entity in febrile children less than five years of age, especially those younger than
three [101, 105]. Mourembou et al found that R. felis is significantly more associated with febrile
children than afebrile children and that several febrile children presented with detectable levels
of R. felis in their blood, suggestive of bacteremia in a situation of active infection [105].
Conversely, Mediannikov et al revealed that some patients bacteremic with R. felis lack an
antibody response and that others are asymptomatic [106, 107], leading them to propose the
possibilities of relapse or recurrent infections or that people may be reservoir hosts. Still another
possibility to consider is cutaneous contamination during sampling, as skin swabs of African
patients have been PCR positive for R. felis [108]. In spite of the inconsistent data surrounding
FBSF, a group of researchers that correctly predicted the chikungunya and Zika virus outbreaks
of the past ten years believe Aedes spp. mosquitoes transmitting R. felis out of Africa will
account for the next global epidemic [109].
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1.2.5. Routes of Transmission to Vertebrates
The most widely accepted method for transmission of R. felis from an arthropod to a
vertebrate is via an infectious bite. This route was presumed with initial identification of FBSF,
further supported by seropositivity in vertebrates post flea-feeding [42], gained traction when
Macaluso et al identified R. felis in the salivary glands of cat fleas [19], and was finally proven
by Brown et al when R. felis transcripts were recovered from flea-feeding sites on mice skin
[26]. Additionally, it has been suggested that contamination of cutaneous wounds (i.e. fleafeeding sites) with infectious flea feces could constitute an alternate route of transmission, as is
the case with Rickettsia prowazekii and Rickettsia typhi, the causative agents of epidemic typhus
and murine typhus, respectively [110-112]. This hypothesis was supported by Reif et al who
established that cat flea feces contains R. felis DNA as far out as 28 days post exposure (DPE)
and additionally that the R. felis was viable, as RNA transcripts were recovered in cat flea feces
at 21 DPE [43]. Further evidence for deposition of R. felis in cat flea feces was provided by
Thepparit et al in 2013 when they used immunofluorescence assays and transmission electron
microscopy to demonstrate the dissemination of R. felis into cat flea excretory organs including
the hindgut, Malpighian tubules, and rectal ampulla [40]. Finally, this route was tested by
Legendre et al [113] who conducted an experiment wherein mice were intradermally inoculated
with infectious doses of R. felis from culture and flea feces. They found sites of inoculation were
significantly positive for R. felis DNA at 24 and 48-hours post exposure, both from culture and
infective flea feces [113]. To date, a timeline of significant milestones in research related to R.
felis is presented (Figure 1).
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Figure 1. A timeline of Rickettsia felis milestones. 1A 1990s. 1B 2000s. 1C 2010s.
13

The current study seeks to further investigate the infectious nature of flea feces,
hypothesizing infectivity of R. felis to vertebrates via ingestion, as is the case for similar
organisms covered in the following section. Preliminary evidence of alimentary exposure to R.
felis is provided by Keita et al who established the presence of R. felis in the feces of both apes
and humans across Africa [114, 115], minimally suggesting exposure via ingestion and, more
ominously, alimentary infection and the possibly of shedding of R. felis in feces – the
implications of which would be considerable for animal and human health globally. From a
veterinary perspective, mammalian grooming behaviors provide ample exposure to fleas and flea
feces; indeed, Wade and Georgi demonstrated that as many as 49.5% of the fleas on a cat end up
in its feces [116]. This route also supports the age bias in humans identified by Mourembou et al,
as younger children – a niche of humans with poor hygiene and indiscriminate oral exposure –
were statistically more likely to contract FBSF [105].
1.3. Ingestion as a Route of Infection of Similar Pathogens
Transmission via ingestion has been observed in several other obligate and facultative
intracellular Alphaproteobacteria. Both Neorickettsia helminthoeca and Neorickettsia risticii are
ultimately ingested by their vertebrate hosts in which they are the causative agents of salmon
poisoning disease and Potomac Horse Fever, respectively [117-119]. Bartonella henselae, the
causative agent of cat-scratch disease, has been reported as transmissible via ingestion in cats
[120], though this finding was not supported by a subsequent investigation [121]. While these
species provide examples of orally transmitted bacteria, other members of Rickttsiales, chiefly
the TG members R. prowazekii and R. typhi, provide the most compelling comparisons.

14

1.3.1. Rickettsia prowazekii
Known as the “scourge of armies” Rickettsia prowazekii is of great historical importance
as the louse-borne causative agent of epidemic typhus. It is estimated to have been the cause of
death of up to 20% of Napoleon Bonaparte’s Grand Armée [122], three million people during the
Russian Revolution of 1917 [123], and many innocents in concentration camps during World
War II [124]. Although in 1995 it was thought to be functionally extinct, an outbreak occurred in
1997 in the African country of Burundi after a civil war displaced a large percentage of the
population into close-quartered refugee camps [125-127].
Transmission of R. prowazekii to humans by the body louse Pedunculus humanus
humanus (Pedunculus humanus corporis) occurs due to contact of infective lice feces or crushed
lice with wounds (i.e. lice-feeding sites), conjunctiva, or mucus membranes, including contact
with the airways via inhalation – a common route of infection for health care workers, as fecal
matter can become particulate [128]. Frighteningly, the infective feces remain viable for up to
100 days [128]. Humans are considered the reservoir host of R. prowazekii, as infection is fatal
to lice; the bacteria rapidly replicate by binary fission, leading to rupture of the midgut epithelial
cells and leakage of the bloodmeal, creating a “red louse” appearance [128]. The initial infection
is treatable with doxycycline, however, a relapse known as Brill-Zinsser disease is known to
occur, even years after the original course of disease [129]. In its recrudescent state epidemic
typhus consists of bacteremia and may continue the transmission cycle, making the possibility of
eradication extremely difficult [128]. This type of recrudescence has been proposed as an
explanation for the inconsistent bacteremia associated with FBSF [33, 106].
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1.3.2. Rickettsia typhi
Similar to R. felis, Rickettsia typhi is found worldwide, causes a near identical menagerie
of clinical signs and disease severity, and is transmitted by fleas. While its chief vector is the
oriental rat flea Xenopsylla cheopis [130], R. typhi is also found in the cat flea [131] and may
coinfect fleas along with R. felis [132]. Moreover, R. typhi and R. felis are transmitted vertically
and horizontally among fleas in a similar manner [17] and neither is detrimental to the flea [130].
Transmission of R. typhi to humans results in murine typhus (endemic typhus) and occurs
through several routes: an infective arthropod bite from fleas infected for more than 21 days
[133], contamination of infective flea feces into wounds (i.e. flea-feeding sites) [134], exposure
of oronasal mucosa including via inhalation [89], and contact with conjunctiva [133]. Infected
fleas will begin shedding infective feces after 10 days [130] and their feces will remain viably
infective for 10 days [112]. Considering the existing similarities and their ability to coinfect, the
possibility of horizontal gene transfer between R. typhi and R. felis that could result in increased
pathogenicity is not beyond the imagination.
1.4. Summary
Rickettsia felis has been identified as an emerging disease marked with the potential to
become the next global epidemic. Predominantly transmitted by the cat flea, Ctenocephalides
felis, it is the causative agent of flea-borne spotted fever in people and is an underrecognized
etiologic agent of fever in animals. Once infected, fleas shed R. felis in their feces. Transmission
from infected arthropods to vertebrates is known to occur via infectious flea bites and strong
evidence suggests transmission occurs via inoculation of wound sites with infective flea feces, as
is the case with typhus group rickettsiae which also have the potential for oronasal transmission
via infective feces. The possibility that R. felis might also be transmitted via ingestion is further
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supported by evidence of R. felis in the feces of both humans and animals. Therefore, our current
study hypothesized that R. felis from culture and from infective cat flea feces would be infective
to mice via ingestion.
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CHAPTER 2. INFECTION POTENTIAL OF RICKETTSIA FELIS VIA
INGESTION
2.1. Introduction
Rickettsia felis is a gram negative, obligate intracellular bacteria (class
Alphaproteobacteria, order Rickettsiales) of the transitional group (TRG) of rickettsiae that is
present mostly within its primary vector and reservoir host, the cat flea (Ctenocephalides felis)
[8, 25]. Transmission within arthropods occurs both vertically and horizontally, suggesting that
vertebrates play a role in the life cycle of R. felis [28, 38]. Further evidence for its association
with vertebrates includes seropositivity in both animals and humans [25, 42]. Case series of
disease in vertebrates that detected only R. felis by means of polymerase chain reaction (PCR)
and/or serology have led to its characterization as the etiologic agent of flea-borne spotted fever
(FBSF) in humans as well as a poorly recognized cause of fever in animals [25, 76, 105]. One
known transmission route to vertebrates is via the bite of infected fleas during feeding [26],
however, closely related members of the typhus group (TG) of rickettsiae, namely Rickettsia
prowazekii and Rickettsia typhi, are shed in feces and can subsequently be transmitted in
wounds, mucus membranes, conjunctiva, and oronasally via inhalation [89, 128, 133]. Our lab
previously investigated the transmission of R. felis via intradermal inoculation to simulate fecal
transmission in cutaneous wounds such as flea-feeding sites. The unpublished results indicate
that the route is viable. Furthermore, there is evidence to support vertebrates are exposed to R.
felis via ingestion, as R. felis has been detected in both human and ape feces [114, 115]. This is
possibly due to the grooming habits of mammals and the poor hygiene of young children – the
human group most infected with FBSF in Africa [105]. In the current study it is hypothesized
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that ingestion of R. felis from culture and from infected cat flea feces will result in the
transmission of R. felis to mice.
2.2. Materials & Methods
2.2.1. Source and Strain of Bacteria, Fleas, and Mice
The experiments performed utilized Rickettsia felis, Ctenocephalides felis, and BALB/c
mice. Rickettsia felis strain LSU (Louisiana State University, passage 3) was cultured in Ixodes
scapularis embryonic cells (ISE6) with L15B complete medium (L15B, 10% ∆FBS, and 10%
tryptase phosphate broth at a pH of 6.8-7.0) in an incubator set at 32˚C and 5% CO2 as originally
described by Pornwiroon et al [48]. Each week a concentrated smear (Figure 2) was made and
stained with Diff-Quik to assess R. felis growth [48]. Fleas used were newly emerged Rickettsiauninfected cat fleas from Elward II (El-Labs, Soquel, CA). BALB/c mice were chosen, as
previous work has described their ability to become infected with R. felis [135]. All mice were
obtained from the Louisiana State University Division of Laboratory Animal Medicine for use as
a murine model of mammalian disease; their gender was randomized, and they were juveniles
with ages ranging from six to seven-week-old mice at the time of procurement.

Figure 2. Rickettsia felis inside ISE6 cells. 1000x magnification oil-immersion, Diff-Quik stain.
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2.2.2. Ethics Statement
This study was conducted in compliance with the Animal Welfare Act (9 CFR Ch. 1
Subpart C 2.31 (c) 1-8), the Guide for the care and use of Agriculture Animals in Agricultural
Research and Training (Ch. 1), and the Public Health Service Policy on Human Care and Use of
Laboratory Animals (Section IV. B. (1-8)). Additionally, all animal-related research was
conducted with approval of the LSU Institutional Animal Care and Use Committee (IACUC;
Protocol Number: 15-115).
2.2.3. Per Oral Administration of Rickettsia felis from Culture
For this experiment 15 test mice and three control mice were organized into three groups,
each consisting of five test mice and one control mouse (Figure 3). Mice were caged according
to gender and treatment status, keeping infected and control mice separated for the duration of
the experiment. R. felis was cultured in ISE6 cells, enumerated with the backlight BacLight
viability staining kit, and sucrose purified. Each test mouse received a solution containing 3.0 x
106 R. felis organisms suspended in sucrose phosphate glutamate (SPG) buffer while each control
mouse received an equivalent volume of SPG buffer only. This number was based on a study
that indicated 3.0 x 106 was the upper range of R. felis per milligram of flea feces using high
passage R. felis (passage 8) [113]. Therefore, this study was designed to simulate ingestion of 1
mg of high passage R. felis-infected flea feces, aiming to recreate a natural exposure event
wherein the dose of R. felis administered mimics the amount that may be ingested via grooming
or poor hygiene in animals or humans, respectively. This experiment was performed in duplicate,
independently, and with R. felis from different culture flasks during the second trial.
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Figure 3. Per oral administration of Rickettsia felis from culture. R. felis was grown in ISE6
cells (culture flasks pictured top left, R. felis within ISE6 cells picture top right), quantified,
sucrose purified, and then suspended in SPG buffer. Test mice were pipette-fed 3.0 x 106 R. felis
organisms while control mice received an equivalent volume of SPG buffer only (central
illustration). Mice were arranged into 3 test groups (bottom left), each with 1 control mouse
(colored gray) and five test mice (colored black). Group 1 was sacrificed 1-day post ingestion,
Group 2 at 7 DPI, and Group 3 at 14 DPI. A full necropsy was performed and heart, liver, spleen,
stomach, and a jejunal segment were collected for gDNA extraction, RNA extraction, and
histopathology. Blood was retrieved via intra-cardiac aspiration in 14 DPI mice.
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2.2.4. Per Oral Administration of Rickettsia felis from Flea Feces
This experiment mirrored the first, consisting of 15 test mice and three control mice once
again arranged into three groups, each with five test mice and one control mouse (Figure 4).
Mice were caged by gender and treatment status, keeping infected and control mice separated for
the duration of the experiment. R. felis was cultured in ISE6 cells, enumerated via the BacLight
viability staining kit, purified, and then resuspended in 600 μL of heat-inactivated bovine blood.
This infectious bloodmeal was provided to a colony of approximately 200 R. felis-uninfected
fleas that had been previously withheld a bloodmeal for 6 hours. The fleas were allowed to feed
on the infectious bloodmeal for 48 hours before it was changed for an uninfected bloodmeal,
which the fleas received for the rest of the experiment. A control colony of fleas was also
maintained in order to procure uninfected flea feces.
Flea feces collection coincided with cage changing and was performed once weekly for
the duration of the experiment. Using a dissecting microscope, cage debris was examined and the
flea feces were carefully separated from flea eggs, larvae, dead fleas, and dried blood. A small
portion of flea feces was weighed and its gDNA was extracted using a Qiagen DNeasy Tissue
Kit (Qiagen, Germantown, MD) per the instructions for tissue extractions then eluted with 25 μL
of PCR-grade H2O. The extracted gDNA was tested via quantitative polymerase chain reaction
(qPCR) using primers for rickettsial ompB [136] and the C. felis 18S rRNA gene [79].
Subsequently, the density of the R. felis load was identified and then used to calculate the weight
of feces required to achieve 3.0 x 106 R. felis organisms. The flea feces were then suspended in
SPG buffer and the correct volume pipette-fed to each test mouse. Control mice received a
solution prepared using the same weight of R. felis-free feces collected from the control colony
of fleas. These feces were verified R. felis-negative via qPCR. As with the first experiment, this
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experiment was performed in duplicate, independently, with R. felis from different culture flasks,
and different flea colonies during the second trial.

Figure 4. Per oral administration of Rickettsia felis from flea feces. Colonies of cat fleas were
fed an infectious bovine bloodmeal (top left). Their feces were isolated (top right) and proven to
be R. felis positive via qPCR. A flea feces dose containing 3.0 x 106 R. felis organisms was
calculated and suspended in SPG buffer. Test mice were pipette-fed infective flea feces and
control mice were fed the same weight of qPCR-proven R. felis-free flea feces in an equivalent
volume of SPG buffer (central illustration). Mice were arranged in 3 groups and sacrificed as in
the previous experiment. Tissues and blood were also collected in the same way.
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While the amount of R. felis each test mouse received remained constant across each trial, due to
an inability to standardize the density of R. felis fleas excrete in their feces, the total weight of
flea feces varied between trials. The variation is largely based on the amount of an infectious
bloodmeal the colony ingests.
2.2.5. Necropsy and Sample Collection
Mice were examined daily up until their sacrifice date for the duration of each
experiment. Group 1 mice were sacrificed at 1-day post ingestion (DPI), Group 2 mice at 7 DPI,
and Group 3 mice at 14 DPI. Mice were humanely euthanized individually, primarily via carbon
dioxide chamber and secondarily via cervical spinal dislocation. Blood was collected from
Group 3 mice via intra-cardiac aspiration, spun, and the serum removed. A full necropsy was
performed on each mouse. Select organs were harvested, including heart, liver, spleen, stomach,
and a jejunal segment, in that order to avoid gastrointestinal contamination. The organs were
sectioned; one piece placed in a cassette and stored in 10% neutral buffered formalin, a second
piece stored in a 1.7 mL Safe-Lock microcentrifuge tube for genomic DNA (gDNA) extraction,
and a third piece stored in 1 mL of TRIzol for RNA extraction. The samples for gDNA
extraction and serum samples were stored at -20 ˚C and the samples for RNA extraction were
stored at -80 ˚C.
2.2.6. Detection of Rickettsia felis in Tissues
Initial detection of R. felis in heart, liver, spleen, stomach, and intestine samples was
performed via qPCR. First, the mouse tissues were homogenized. This process involved the
addition of two stainless steel beads, proteinase K, and buffer ATL to each of the 1.7 mL SafeLock microcentrifuge tubes. The samples were then run twice through the Tissue-Lyser (Qiagen,
Valencia, CA) at 30 Hz for three minutes each cycle. Genomic DNA was then extracted per the
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manufacturer’s instructions using the Qiagen DNeasy Tissue Kit, eluting with 25 μL PCR-grade
H2O. Tissue samples were processed in batches of 30, which included all samples from a single
timepoint of one experiment (i.e. 1 DPI R. felis from culture, replicate 1) and an environmental
control containing only extraction reagents was included in every batch of extractions. Likewise,
all samples from a timepoint were run on a single qPCR plate, along with the environmental
control from the extraction process, a negative control consisting only of PCR-grade H2O and
master mix, as well as two positive controls, one for R. felis and one for mouse. The qPCR was
performed using a LightCycler 480 Real-Time PCR system (Roche), standard sets for both mice
and R. felis, as well as primers for rickettsial ompB [136] and the mouse cfd [137]. Results were
viewed as rickettsial copy numbers per sample and were considered positive if two of three
replicates showed amplification before cycle 35, if negative and positive controls were correctly
amplified, and if the standard curve was appropriate.
Select test samples, as well as their control sample counterparts, were chosen for
histopathology and immunohistochemistry (IHC) based on qPCR results. Once formalin fixation
was complete, these tissues were submitted for paraffin-embedding and were subsequently
sectioned for hematoxylin and eosin (H&E) staining and IHC using polyclonal anti-Rickettsia
antibodies diluted to 1/1000 as described previously by Grasperge et al [137]. All H&E and IHC
slides were read and interpreted by an anatomic pathologist certified by the American College of
Veterinary Pathologists.
2.2.7. Detection of Rickettsia felis in Serum
Based on initial tissue sample qPCR findings, the serum of one mouse was selected for
qPCR detection of R. felis as well as an indirect immunofluorescence assay for detection of an
antibody response to R. felis. Genomic DNA was extracted from the serum and an environmental
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control consisting only of extraction reagents using a Qiagen DNeasy Tissue Kit (Qiagen,
Germantown, MD) and the protocol for gDNA extraction from non-nucleated blood. The sample
was eluted with 25 μL of PCR-grade H2O and qPCR was performed using primers for rickettsial
ompB and mouse cfd on a LightCycler 480 Real-Time PCR system (Roche). Samples were
considered positive if two of three replicates showed amplification before cycle 35.
The serum was also tested using an indirect immunofluorescence assay as described in
previous studies [35]. R. felis from culture was fixed to a glass slide with 4% PFA and allowed to
sit for 15 minutes. The slide was then washed three times five minutes apart with PBS. A
blocking solution consisting of 3% BSA in PBS was applied and allowed to incubate for 1-hour
at room temperature. Serum was diluted 1:100, applied to the slide, and allowed to sit at room
temperature for one hour. Once again, the slide was washed three times five minutes apart with
PBS. Finally, a secondary antibody (goat anti-mouse IgG conjugated to horseradish peroxidase
diluted 1:1000 in blocking buffer) was applied and the slide was incubated at room temperature
in the dark for 30 minutes. A mounting solution with added DAPI was then applied prior to
cover-slipping. Samples were read using fluorescence microscopy (Leica).
2.2.8. Assessment of Rickettsia felis Viability
PCR-positive tissue samples stored in TRIzol were further processed using the Bio-Rad
iScript™ cDNA Synthesis Kit for reverse transcription quantitative PCR (RT-qPCR) to test the
viability of R. felis organisms detected. First, the tissue samples were homogenized as previously
described for gDNA extraction from tissue samples. Next, 200 μL of chloroform was added
before vortexing and incubating the samples at room temperature for three minutes. The samples
were then subjected to 15 minutes of centrifugation at 12,000 x g and 4˚C. The aqueous phase of
the samples was pipetted-off, transferred to a new microcentrifuge tube, and 500 μL of
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isopropanol was added. The samples were incubated overnight at -20˚C for increased RNA yield.
Once precipitated, the samples were centrifuged at 12,000 x g and 4˚C for 10 minutes. The
supernatant was pipetted-off, the pellet was washed with 1 mL of 75% ethanol, and the samples
were vortexed and then centrifuged at 7,500 x g and 4˚C for 5 minutes. The supernatant was
discarded and the RNA was allowed to air-dry for 10 minutes before resuspending with 25 μL of
pre-warmed PCR-grade H2O. The samples were then incubated at 60˚C for 15 minutes. The
samples were then subjected to two cycles of DNAse treatment, by combining with 5 μL 10x
DNAse buffer, 1 μL Turbo DNAse, and 24 μL PCR-grade H2O before incubating at 37˚C for 30
minutes. An additional 5.77 μL 10x DNAse buffer and 2 μL Turbo DNAse were added before
being incubated at 37˚C for 30 minutes once again. The samples were then subjected to an RNA
clean-up step as previously described [26]. A preliminary RT-qPCR was performed on all
samples without the addition of iScript™ reverse transcriptase in order to establish the samples
were free of DNA. Finally, the complementary DNA (cDNA) was generated from the samples
with the addition of iScript™ reverse transcriptase as previously described [26], and RT-qPCR
was performed on the samples, an environmental control from the RNA extraction process, a
negative control consisting only of reagents and PCR-grade H2O, a negative control lacking
iscript reverse transcriptase, and R. felis and mouse positive controls using rickettsial ompB and
mouse cfd on a LightCycler 480 Real-Time PCR system (Roche). Samples were considered
positive if two of three replicates showed amplification before cycle 35.
2.3. Results
2.3.1. Per Oral Administration of Rickettsia felis from Culture
Two replicates of the experiment were performed. All mice made it to their intended
sacrifice dates without developing clinical signs of disease. Moreover, gross lesions were not
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appreciated during the necropsy of any mouse. Genomic DNA was successfully extracted from
the heart, liver, spleen, stomach, and intestines of each mouse and qPCR was successfully
performed on all samples (Table 1). Of the five mice that had detectable levels of R. felis, three
of them had two organs with detectable levels. Furthermore, all mice with detectable R. felis in
more than one organ had detectable R. felis in their spleen. No mice had detectable levels of R.
felis in either their stomach or intestine. The serum of an individual mouse that had detectable
levels of R. felis in its heart and spleen was tested and found to be negative.
Table 1. Detection of R. felis from culture via qPCR

Quantitative PCR results of test mice from both replicates of the R. felis from culture model of
ingestion. Detectable levels of R. felis occurring before PCR cycle 35 were considered positive.
Two mice had detectable R. felis in their hearts, two in their livers, and four in their spleens. No
mice had detectable levels of R. felis in their stomach or intestine. Samples marked with (*)
indicate they came from a mouse with more than one positive sample. Percentages shown
parenthetically. All samples from the control mice of both replicates were negative for R. felis.
All tissue samples of the two test mice with the highest R. felis densities (data not shown)
and presence of R. felis in more than one organ were submitted for histopathology (Figure 5).
These mice included “Rf10.1” from the 7 DPI time-point with detectable R. felis in its
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Figure 5. Histopathology of mouse samples post-ingestion of R. felis from culture. All
images to the right are of test mouse Rf13.1 (sacrificed 14 DPI) and images to the left are from
the associated control mouse (hematoxylin and eosin stain, 100x). A, B. Heart. C, D. Liver. E, F.
Spleen. G, H. Stomach. I, J Intestine. No evidence of disease is appreciated in any organ. Rf10.1
had similar findings (histopathology not shown).
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liver and spleen and “Rf13.1” from the 14 DPI time-point with detectable R. felis in its heart and
spleen. All tissue samples from the control mice associated with these test mice were submitted
for comparison. Histopathology performed by a board-certified veterinary anatomic pathologist
concluded that no evidence of disease was present in any samples.
Additionally, the qPCR positive organs of Rf10.1 and Rf13.1 were sectioned for
immunohistochemistry (IHC) with a polyclonal anti-Rickettsia antibody diluted 1:1000 as
previously described [137]. Of the four test organs analyzed with IHC, the spleen of Rf10.1 had
few positively staining bacteria interpreted as R. felis (Figure 6). No other samples were
considered positive.

Figure 6. Anti-Rickettsia immunohistochemistry of mouse spleen post-ingestion of R. felis
from culture. A. 400x photomicrograph of the spleen of the R. felis from culture 7DPI test
mouse Rf10.1. R. felis organisms are observed both intracellularly and possibly in the
extracellular space (red box). B. Inset with an expanded view of R. felis organisms in the red
box. R. felis organisms are observed intracellularly and possibly also in the extracellular space.
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An indirect immunofluorescence assay was performed on serum from Rf13.1 in order to
determine if antibodies against R. felis were present. The serum was positive, as indicated by the
fluorescent secondary antibody binding the mouse antibodies against R. felis which in turn bound
a primary fixed layer of R. felis from culture (Figure 7).

Figure 7. Indirect immunofluorescence assay of mouse serum post-ingestion of R. felis from
culture. A. 1000x oil immersion photomicrograph of the test sample (serum from 14DPI R. felis
from culture test mouse Rf13.1) demonstrates green fluorescence associated with binding of goat
anti-mouse secondary antibody (dilution 1:1000) to mouse antibodies directed at R. felis. B.
1000x oil immersion photomicrograph of the negative control lacks immunofluorescence.

All tissue samples of Rf10.1 and Rf13.1, as well as the tissue samples of their associated
control mice, were analyzed using RT-qPCR. The samples were initially processed without
iscript ® reverse transcriptase to ensure no background amplification of rickettsial ompB was
present. Once processed with iscript ® reverse transcriptase, no cDNA samples exhibited
detectable levels of R. felis.
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2.3.2. Per Oral Administration of Rickettsia felis from Flea Feces
As with the first experiment, two replicates of per oral administration of R. felis from flea
feces were performed. Once again, all mice made it to their intended sacrifice dates without
developing clinical signs of disease. Moreover, gross lesions were not appreciated during the
necropsy of any mouse. Genomic DNA was successfully extracted from the heart, liver, spleen,
stomach, and intestines of each mouse and qPCR was successfully performed on all samples
(Table 2). As all samples were negative, no additional tests were performed.

Table 2. Detection of R. felis from flea feces via qPCR

Quantitative PCR results of test mice from both replicates of the R. felis from flea feces model of
ingestion. No samples exhibited detectable levels of R. felis occurring before PCR cycle 35. The
control mice associated with both replicates of this experiment were also negative for R. felis.
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CHAPTER 3. DISCUSSION & FUTURE DIRECTIONS
Owing to its similarities with typhus group Rickettsia, Rickettsia felis has been identified
as a pathogen that is potentially transmitted in flea feces by contact with mucus membranes. The
supporting evidence for this route of infection includes the tropism of R. felis for flea midgut
epithelial cells, Malpighian tubules, and rectal ampulla [40], proof that fleas shed viable R. felis
organisms in their feces, and the discovery of R. felis in mammalian feces, suggesting alimentary
passage [114, 115]. Theoretically, this route of transmission may also account for the
predilection of young children in sub-Saharan Africa to contract R. felis-induced flea-borne
spotted fever (FBSF) [105], due to frequent oral exposure. Along those lines, mammals such as
cats and non-human primates with meticulous grooming habits would stand to have
exceptionally increased risk for oral exposure to infective flea feces, potentially contributing to
disease as a poorly characterized cause of fever.
Interestingly, several putative genes have been identified that could ameliorate the role of
R. felis as a pathogen transmissible via ingestion. Chiefly, R. felis contains a hyaluronidase that
has been shown to be highly similar to that of Clostridium perfringens, one of the most common
causes of food poisoning largely due to the actions of its hyaluronidase on the gastrointestinal
epithelial cells. Also known as a “spreading factor,” hyaluronidase is proposed as a means for
degrading polysaccharides such as those holding mammalian tissues together. Additionally, R.
felis contains an ortholog (Rf0371) to RickA of Rickettsia conorii which is tied to mobility via
actin polymerization [46]. Best demonstrated by Listeria monocytogenes, actin polymerization is
an effective means for entering cells by force subsequent to the creation of a posterior actin trail.
Ogata et al were [46] able to visualize R. felis actin filaments and differentiate them from host
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cell stress fibers with immunofluorescence microscopy, providing further support for functional
actin mobility in R. felis.
In light of this mounting support, we hypothesized that R. felis would be infective to
vertebrates via ingestion. Specifically, we designed sister experiments to test this theory with R.
felis from culture as well as R. felis in cat flea feces. We utilized BALB/c mice as a model of
vertebrate disease in order to compare results with a previous transmission study investigating
the infectivity of R. felis-laden cat flea feces via dermal inoculation [113]. Likewise, our
infectious dose of 3.0 x 106 R. felis organisms was chosen to represent the upper range of R.
felis-burden of 1 milligram of cat flea feces [113], approximating the amount that a small child
or other small mammal could be expected to ingest through indiscriminate oral exposure or
grooming behaviors.
Our results indicate that R. felis is capable of infecting mice via ingestion, as determined
by positive qPCR findings in the R. felis from culture experiment. Specifically, 5 out of 30 test
mice orally administered R. felis from culture had rickettsial DNA at sites distant from the
gastrointestinal tract, indicating an infection rate of 17%. Of the infected mice, we recovered
rickettsial ompB in 80% of spleens (4/5 mice) and 40% of hearts and livers (2/5 mice each).
Moreover, the majority of mice that were infected exhibited more than one organ with detectable
levels of R. felis (3/5 mice). Furthermore, R. felis detected via qPCR was additionally
corroborated by the positive staining of low numbers of R. felis organisms with anti-Rickettsia
immunohistochemistry in the spleen of an individual mouse. While detection of R. felis in
mammalian viscera has been previously demonstrated [26, 95, 138], the ability of ingested R.
felis to disseminate to distant organs is a novel finding with broad implications for how R. felis is
potentially transmitted to, among, and within vertebrate hosts.
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Transmission of R. felis to vertebrate hosts has been established through infectious cat
flea bites [26] and intradermal inoculation of infective flea feces [113]. Here we have been able
to demonstrate alimentary transmission of R. felis from culture, though our attempts to transmit
R. felis to mice via ingestion of infective cat flea feces failed. While no conclusions may be
drawn regarding the infectivity of R. felis in cat flea feces via ingestion in mice, we can speculate
on the ways in which mammals might come to ingest R. felis outside of cat flea feces. One
possible route would be via ingestion of whole cat fleas – or other arthropods – infected with R.
felis. This model of transmission was explored with negative results by Foil et al [121] as a
means for transmission of Bartonella henselae in cats, though to the author’s knowledge this
route has yet to be explored for R. felis. Transmission of R. felis may also occur via ingestion of
cutaneous R. felis, as Mediannikov et al [108] demonstrated that R. felis may be ubiquitous in
environments of high prevalence, such as parts of Senegal. Specifically, cotton swabs of nondiseased skin of Senegalese people revealed detectable levels of R. felis via qPCR [108]. Thus,
through routine grooming or indiscriminate oral habits, animals and young children might come
in contact with free R. felis organisms; whether or not these organisms are viable remains to be
seen.
The possibility of R. felis transmission directly between vertebrates has been poorly
explored and not yet proven, however, if transmission of ingested material can result in infection,
additional avenues of exposure arise. One route might be the ingestion of infectious feces of
other vertebrates. Some species, such as dogs, regularly exhibit coprophagia behavior, and
subsequently might become infected via a fecal-oral route. Though R. felis has been shown to be
viable in flea feces, viability of R. felis in vertebrate feces has yet to be established. Another
potential route of transmission between vertebrates is via ingestion of other vertebrate organisms
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infected with R. felis, as suggested by De Nys et al [139] regarding the presence of R. felis in the
feces of non-human primates. This route would be especially applicable to cats due to their
predatory nature and is further supported by evidence that many species of small mammals can
be infected with R. felis [73, 74, 77, 138].
The current study also raises questions regarding the dissemination of R. felis within
vertebrate hosts. Our results suggest that R. felis was not only able to survive the extreme acidity
of the stomach, it was able to successfully contend with several innate barriers of the intestines,
including mucus, anti-microbial peptides, and commensal bacteria well-adapted to monopolizing
available space and resources [140]. The mucus present within the gastrointestinal tract variably
consists of two specialized layers: a thin, easily-removed top layer present throughout the
gastrointestinal tract and a dense bottom layer firmly adhered to the epithelial cells that is absent
only in the small intestines [141]. One means of breaking through the mucus is via glycosidases,
enzymes necessary for the degradation of mucin oligosaccharides [140], which have not been
attributed to R. felis at this time. Therefore, unless the single mucin layer of the small intestine is
removed through pre-existing disease, it is likely that R. felis requires an alternative route to
infection. One option would be the microfold cells (M-cells) located throughout the
gastrointestinal tract in mucosal-associated lymphoid tissues (MALT) and in the Peyer’s patches
of the small intestine. As these cells are uniquely uncovered by mucus at all times, they may
provide a consistent surface by which R. felis might attach through the actions of its sca genes,
including ompB. Furthermore, the M-cells might provide critical access to cells of the immune
system, chiefly macrophages, for which R. felis has known tropism [142]. Subsequently, as the
infected macrophages circulate, R. felis might be able to disseminate to distant sites, such as the
spleen, liver, or heart. Alternatively, R. felis has also demonstrated tropism for endothelial cells
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[142]. Therefore, if the gastrointestinal tract has pre-existing ulcerative disease, R. felis might
gain easy access to these cells and move cell-to-cell via actin polymerization in a manner similar
to Listeria monocytogenes, or gain entry to the bloodstream for metastatic spread, again leading
to R. felis presence in distant organs. Lastly, R. felis might employ hyaluronidase to burrow its
way to endothelial cells or macrophages, a process that may even occur in the oral cavity or
esophagus.
While our study demonstrates the ability of R. felis to infect mice via ingestion, it notably
does so without inducing an inflammatory response. All sections of test mice tissue positive for
R. felis via qPCR lack overt histopathologic changes as compared to control mice sections.
Furthermore, the splenic tissue positive via immunohistochemistry (IHC) for R. felis
demonstrates a complete lack of inflammation at the site of the bacteria. This finding suggests
that R. felis is capable of effectively evading the immune system, a trait shared with other
obligate intracellular bacteria. Considering its low numbers despite a lack of immune pressure, it
is plausible that R. felis bides its time and replicates slowly in infected mammalian cells,
potentially further avoiding notice by the host immune system. This would explain the relatively
low number of organisms detected by all methods in infected mice throughout all time-points.
Additionally, this would explain the negative RT-qPCR results from tissues that were positive
for R. felis DNA via qPCR, as the low total number of organisms might preclude detection.
Furthermore, even though RT-qPCR was negative, the R. felis observed are thought to be viable
considering their transit from the gastrointestinal tract to a distant site of infection. This is
supported by the finding that R. felis from IHC were observed in groups, suggesting some
replication did occur.
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Although the infected test mice failed to mount a cell-mediated immune response, we
demonstrated the presence of a humoral response in the individual infected mouse we tested via
an indirect immunofluorescence assay. This finding is in line with many earlier studies that have
documented antibodies to R. felis in vertebrates [42, 85, 96, 97]. Humoral responses are
ineffective at eliminating intracellular bacteria, in contrast to cell-mediated responses that deploy
cytotoxic T-lymphocytes. Interestingly, some bacteria are capable of modulating the host
immune system in order to direct the host towards an ineffective immune response, thus
increasing odds of survival [143]. While it is unknown at this time whether R. felis is capable of
this, it would help to explain the observed lack of a cell-mediated immune response as well as
the inconsistent presence of humoral responses observed in the literature [33, 106].
Further studies are needed to better characterize all aspects of transmission of R. felis to
vertebrates via ingestion. Here we tested a single dose and strain of R. felis in a single strain of
mice, leaving much to be elucidated. While we were unsuccessful at transmitting R. felis to mice
via ingestion of infective flea feces, the dose used is still relatively low depending on how much
infective flea feces is consumed. Our model is based on consumption of 1 mg of flea feces with
high passage R. felis, though it is conceivable that both animals and young children could
consume more flea feces by weight or that the R. felis may be of a lower passage. Furthermore,
mammalian feces – particularly from animals and people with documented R. felis infection –
should continue to be inspected for R. felis, not only via qPCR but also with RT-qPCR to
determine R. felis viability. If such feces are found to contain viable R. felis, increased measures
protecting both animals and people from exposure could then be employed. Additionally, the
pathogenesis of R. felis via ingestion requires further investigation. While we have provided
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several possibilities based on the known genes of R. felis, the function of these genes remains
putative in in vivo mammalian cells and must be further characterized.
It is important to note the many variables at play with disease transmission, including
rickettsial strain, type of arthropod vector, type of mammalian target, and route of infection.
Each of these factors may affect the outcome of transmission, whether or not disease ensues, and
the severity of such disease. Considering this complexity, it is not surprising that Koch’s
postulates have gone unfulfilled. Our study identified that organs infected with R. felis exhibit a
low burden up to 14 DPI, therefore highly efficient methods of recovering these bacteria,
potentially incorporating a host cell lysis step and separation via flow cytometry, might improve
chances for culturing R. felis from infected animals.
In conclusion, the present study has demonstrated that ingestion of R. felis serves as a
viable route of transmission and subsequent infection in mice. Additionally, this study has
provided evidence that R. felis is capable of disseminating to distant organs from the starting
point of the gastrointestinal tract and that it can do so without inducing inflammation. We have
also provided further evidence of a humoral response post-infection with R. felis. Our findings
have increased the plausibility of several additional avenues of transmission, including
transmission between vertebrates via ingestion of infective vertebrate tissues or infective
vertebrate feces. Moreover, we have posited theories detailing how R. felis is able to escape the
gastrointestinal tract and metastasize. All considered, this study has expanded the current
understanding of R. felis to include transmission via ingestion, opening many avenues for further
investigation.
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